OTCMKTS:BPSR

Organicell Regenerative Medicine News Headlines

$0.14
+0.00 (+1.09 %)
(As of 06/18/2021 03:58 PM ET)
Add
Compare
Today's Range
$0.13
$0.15
50-Day Range
$0.05
$0.60
52-Week Range
$0.04
$0.63
Volume1.44 million shs
Average Volume4.53 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Organicell Regenerative Medicine (OTCMKTS BPSR) News Headlines Today

SourceHeadline
Organicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTMOrganicell Announces Positive Results of Their Expanded Access Trial for the Treatment of Mild to Moderate COVID-19 Using ZofinTM
finance.yahoo.com - June 15 at 11:56 AM
Albert Mitrani Sells 290,000 Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) StockAlbert Mitrani Sells 290,000 Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Stock
americanbankingnews.com - June 12 at 11:18 AM
Insider Selling: Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Insider Sells 150,000 Shares of StockInsider Selling: Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Insider Sells 150,000 Shares of Stock
americanbankingnews.com - June 12 at 11:18 AM
Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) CFO Sells $39,200.00 in StockOrganicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) CFO Sells $39,200.00 in Stock
americanbankingnews.com - June 12 at 11:18 AM
Short Interest in Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Declines By 61.9%Short Interest in Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Declines By 61.9%
americanbankingnews.com - June 12 at 8:38 AM
Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™Organicell Launches Autologous Blood Derived Platform PPX™ – Patient Pure X™
finance.yahoo.com - June 9 at 9:31 AM
Albert Mitrani Sells 190,000 Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) StockAlbert Mitrani Sells 190,000 Shares of Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Stock
americanbankingnews.com - June 1 at 11:14 PM
Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Insider Sells $25,200.00 in StockOrganicell Regenerative Medicine, Inc. (OTCMKTS:BPSR) Insider Sells $25,200.00 in Stock
americanbankingnews.com - June 1 at 11:14 PM
Organicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual MeetingOrganicell To Present Results Of Zofin™ Clinical Studies At The International Society Of Cell And Gene Therapy Annual Meeting
finance.yahoo.com - May 25 at 12:39 PM
Organicell Signs an Exclusive Distribution Agreement with Apex Services in PakistanOrganicell Signs an Exclusive Distribution Agreement with Apex Services in Pakistan
finance.yahoo.com - May 19 at 7:45 AM
Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19Organicell Receives Approval in Pakistan for the Use of Zofin™ for Compassionate Grounds for COVID-19
finance.yahoo.com - May 11 at 9:04 AM
Organicell Begins Up-Listing Process On NASDAQ ExchangeOrganicell Begins Up-Listing Process On NASDAQ Exchange
finance.yahoo.com - May 4 at 8:05 AM
Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial ExpansionOrganicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion
finance.yahoo.com - April 28 at 12:24 PM
Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™
finance.yahoo.com - April 22 at 10:04 AM
Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of OsteoarthritisOrganicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis
finance.yahoo.com - April 21 at 8:41 AM
Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic PotentialOrganicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential
finance.yahoo.com - April 14 at 10:14 AM
Organicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic PotentialOrganicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic Potential
finance.yahoo.com - March 23 at 10:16 AM
‘Frontiers in Medicine’ Publishes Organicell’s Case Report Demonstrating the Use of Zofin™ in the Treatment of COVID-19 Patients‘Frontiers in Medicine’ Publishes Organicell’s Case Report Demonstrating the Use of Zofin™ in the Treatment of COVID-19 Patients
finance.yahoo.com - March 18 at 9:26 AM
Organicell Announces FDA Approval of IND Application for the Use of Zofin™ in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)Organicell Announces FDA Approval of IND Application for the Use of Zofin™ in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
finance.yahoo.com - January 28 at 9:24 AM
The Forgotten Ones. Will Long-Haulers Be the Next Public Health Crisis?The Forgotten Ones. Will Long-Haulers Be the Next Public Health Crisis?
finance.yahoo.com - January 12 at 9:41 AM
Organicell Regenerative Medicine and Its Investigational Therapeutic Zofin™ Featured in Two National Publications Examining Potential Therapies for COVID-19 Long-HaulersOrganicell Regenerative Medicine and Its Investigational Therapeutic Zofin™ Featured in Two National Publications Examining Potential Therapies for COVID-19 Long-Haulers
finance.yahoo.com - December 29 at 9:21 AM
Organicell Regenerative Medicine, Inc. Becomes Current with SEC Reporting RequirementsOrganicell Regenerative Medicine, Inc. Becomes Current with SEC Reporting Requirements
finance.yahoo.com - December 22 at 8:17 AM
Organicell Announces Additional Site for Phase I/II Clinical Trial of Zofin™ for Treatment of COVID-19Organicell Announces Additional Site for Phase I/II Clinical Trial of Zofin™ for Treatment of COVID-19
finance.yahoo.com - November 18 at 7:11 AM
Organicell advancing study of Zofin for COVID-19Organicell advancing study of Zofin for COVID-19
seekingalpha.com - November 13 at 8:21 AM
Organicell Provides Update on Its COVID-19 Clinical Trial Using ZofinTMOrganicell Provides Update on Its COVID-19 Clinical Trial Using ZofinTM
finance.yahoo.com - November 12 at 7:18 AM
Organicell Partners with Regenerative Care Network to Study Potential Therapeutic Benefits of Zofin™ for Patients with Heart FailureOrganicell Partners with Regenerative Care Network to Study Potential Therapeutic Benefits of Zofin™ for Patients with Heart Failure
finance.yahoo.com - October 20 at 9:42 AM
Organicell Regenerative Medicine Inc (BPSR)Organicell Regenerative Medicine Inc (BPSR)
nasdaq.com - October 16 at 7:32 PM
Organicell Regenerative Medicines Zofin nabs accelerated review in U.S. to treat COVID-19 patientsOrganicell Regenerative Medicine's Zofin nabs accelerated review in U.S. to treat COVID-19 patients
seekingalpha.com - September 29 at 2:24 PM
Three New COVID-19 Patients Treated with Zofin™ Report ImprovementThree New COVID-19 Patients Treated with Zofin™ Report Improvement
finance.yahoo.com - September 2 at 7:14 AM
First Reported “Long-Hauler” Post COVID-19 Patient Treated with Zofin™ Produces Excellent Preliminary ResultsFirst Reported “Long-Hauler” Post COVID-19 Patient Treated with Zofin™ Produces Excellent Preliminary Results
businesswire.com - August 20 at 12:48 PM
First Reported "Long-Hauler" Post COVID-19 Patient Treated with Zofin™ Produces Excellent Preliminary ResultsFirst Reported "Long-Hauler" Post COVID-19 Patient Treated with Zofin™ Produces Excellent Preliminary Results
finance.yahoo.com - August 20 at 7:47 AM
Organicell to initiate early-stage study of its lead candidate for COVID-19Organicell to initiate early-stage study of its lead candidate for COVID-19
seekingalpha.com - August 18 at 1:05 PM
Organicell Phase I/II Clinical Trial UpdateOrganicell Phase I/II Clinical Trial Update
finance.yahoo.com - August 18 at 7:50 AM
Organicell Completes Capital Raise from Retrograde InvestmentsOrganicell Completes Capital Raise from Retrograde Investments
finance.yahoo.com - August 13 at 9:33 AM
FDA Approves Two Emergency INDs for COVID-19 Outpatient TherapyFDA Approves Two Emergency INDs for COVID-19 Outpatient Therapy
finance.yahoo.com - August 6 at 11:30 AM
Organicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 PatientsOrganicell Reports Positive Results from Compassionate Use of Organicell Flow in Severely Ill COVID-19 Patients
finance.yahoo.com - May 27 at 8:12 AM
Investors Search for Promising Covid CuresInvestors Search for Promising Covid Cures
www.forbes.com - May 21 at 8:40 AM
BPSR Organicell Regenerative Medicine Inc - Ordinary SharesBPSR Organicell Regenerative Medicine Inc - Ordinary Shares
www.nasdaq.com - May 20 at 10:38 PM
FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19FDA Approves Two Emergency INDs to Administer Organicell Flow for COVID-19
finance.yahoo.com - May 19 at 9:41 AM
Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19Organicell Announces FDA Approval of IND Application for the Treatment of SARS Due to COVID-19
finance.yahoo.com - May 5 at 12:07 PM
Organicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting StatusOrganicell Regenerative Medicine Inc. Provides Update On Operations and Financial Reporting Status
finance.yahoo.com - January 21 at 4:16 PM
Organicell Regenerative Medicine IncOrganicell Regenerative Medicine Inc
markets.ft.com - October 12 at 10:16 PM
Organicell Welcomes Dr. George C. Shapiro To The Medical Advisory BoardOrganicell Welcomes Dr. George C. Shapiro To The Medical Advisory Board
finance.yahoo.com - February 25 at 4:38 PM
Organicell Regenerative Medicine Inc., Biotech Products Services and Research, Inc. Update for ShareholdersOrganicell Regenerative Medicine Inc., Biotech Products Services and Research, Inc. Update for Shareholders
finance.yahoo.com - January 30 at 4:21 PM
This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.